The Role of Science at the JP Morgan Healthcare Conference

Pharmaceutical Executive: What is the role of science and research at a conference like JP Morgan Healthcare?
Jeff Liter: As a company, we generally lead with science in the approaches that we take. For us, we ask if we can demonstrate that the science has clinical outcomes. Going into JP Morgan this year, we have nine patients under our belt.

Last year, we only had two, so our numbers are starting to get more statistically significant. At JP Morgan, it’s about showing what clinical...